Literature DB >> 11952401

What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts.

Andrew I Jobling1, Robert C Augusteyn.   

Abstract

Prolonged use of glucocorticoids is a significant risk factor for the development of posterior subcapsular cataract. This places restrictions on the use of glucocorticoids in the treatment of systemic and/or ocular inflammatory conditions as well as in organ transplantation. The mechanisms responsible for the opacification are unknown and no effective treatment, other than surgical removal of the lens, is available. Difficulties in establishing suitable in vivo or in vitro models have limited research in this area. Nevertheless, several mechanisms, based on observations with other types of cataracts, have been proposed. In this review, these mechanisms are evaluated in light of the evidence available. A novel mechanism is also proposed, in which steroids do not directly act on the lens but rather affect the balance of ocular cytokines and growth factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11952401     DOI: 10.1111/j.1444-0938.2002.tb03011.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  35 in total

Review 1.  Sustained-release steroids for the treatment of diabetic macular edema.

Authors:  Alejandra Daruich; Alexandre Matet; Francine Behar-Cohen
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

2.  The effect of inhaled steroids on the intraocular pressure.

Authors:  Sujani Shroff; Reji Koshy Thomas; George D'Souza; Suneetha Nithyanandan
Journal:  Digit J Ophthalmol       Date:  2018-05-12

3.  Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophy.

Authors:  Ingrid E C Verhaart; Hans Heemskerk; Tatyana G Karnaoukh; Ingrid G M Kolfschoten; Anne Vroon; Gert-Jan B van Ommen; Judith C T van Deutekom; Annemieke Aartsma-Rus
Journal:  Hum Gene Ther       Date:  2012-01-26       Impact factor: 5.695

4.  Multiple Adverse Effects of Systemic Corticosteroids: A Case Report.

Authors:  Divya Satyanarayanasetty; Kavitha Pawar; Pratibha Nadig; Almelu Haran
Journal:  J Clin Diagn Res       Date:  2015-05-01

5.  The J-shape association of serum total IgE levels with age-related cataract.

Authors:  Sangshin Park; Nam-Kyong Choi
Journal:  Int J Ophthalmol       Date:  2018-06-18       Impact factor: 1.779

6.  Risk factors for cataracts in systemic lupus erythematosus (SLE).

Authors:  Khaled Alderaan; Vuk Sekicki; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2014-09-26       Impact factor: 2.631

7.  Inhibition of Noncanonical Murine Double Minute 2 Homolog Abrogates Ocular Inflammation through NF-κB Suppression.

Authors:  Yan Fan; Wei Zhang; Aiguo Ni; Biraj Mahato; Sai H Chavala
Journal:  Am J Pathol       Date:  2018-07-03       Impact factor: 4.307

8.  Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.

Authors:  Kimberly F Whelan; Kayla Stratton; Toana Kawashima; John W Waterbor; Robert P Castleberry; Marilyn Stovall; Charles A Sklar; Roger J Packer; Pauline Mitby; Candice L Aitken; Julie Blatt; Leslie L Robison; Ann C Mertens
Journal:  Pediatr Blood Cancer       Date:  2010-01       Impact factor: 3.167

Review 9.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

Review 10.  Fluocinolone acetonide intravitreal implant (Iluvien®): in diabetic macular oedema.

Authors:  Mark Sanford
Journal:  Drugs       Date:  2013-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.